Mineralys Therapeutics, Inc.
MLYSReported to SECin USCIK 0001933414Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 33. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Slingsby Brian Taylor— | Open-market sell | $3,005,303104,320 shares | Sep 24, 2026 | Slingsby Brian Taylor | $3,005,303 | Open-market sell | 104,320 | Sep 24, 2026 |
| Warren EricChief Commercial Officer | Option exercise | nothing paid7,438 shares | Sep 22, 2026 | Warren EricChief Commercial Officer | nothing paid | Option exercise | 7,438 | Sep 22, 2026 |
| Warren EricChief Commercial Officer | Open-market sell | $209,1367,438 shares | Sep 22, 2026 | Warren EricChief Commercial Officer | $209,136 | Open-market sell | 7,438 | Sep 22, 2026 |
| Warren EricChief Commercial Officer | Option exercise | $98,4797,438 shares | Sep 22, 2026 | Warren EricChief Commercial Officer | $98,479 | Option exercise | 7,438 | Sep 22, 2026 |
| Karydas Daphne— | Option exercise | nothing paid3,000 shares | Sep 17, 2026 | Karydas Daphne | nothing paid | Option exercise | 3,000 | Sep 17, 2026 |